dihexa chemical structure | CAS 1401708-83-5 Dihexa (PNB-0408) | Angiotensin IV

The authors reported improved Morris water maze performance (reduced escape latency over the training days), increased synaptophysin (a synaptic-density marker), and lower IL-1 and TNF-, with effects attributed to PI3K/AKT signaling

Human clinical work cited in popular press is generally fosgonimeton work, not Dihexa work

Lancet 396 , 819829 (2020)

That's not speculation

Its compounding-pathway status is unsettled: ibutamoren mesylate was nominated for inclusion on FDA's Section 503A bulk drug substances list, and the Pharmacy Compounding Advisory Committee reviewed the nomination at its October 29, 2024 meeting and voted against recommending it for the list, citing concerns about the strength of the safety and efficacy evidence

Why lean mass measurements are an imperfect proxy for muscle health and function [21:45]